The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $95.0 for DexCom over the last 3 months.
Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...
Dexcom, one of the leading continuous blood glucose ... This means that the 1.7 million-plus global Dexcom users won't need ...